Monoclonal antibodies in the treatment of central nervous system malignancies.
Kemshead
J T
JT
Imperial Cancer Research Fund Paediatric & Neuro-Oncology Group, Bristol, U.K.
Papanastassiou
V
V
Coakham
H B
HB
Pizer
B L
BL
D000293:Adolescent; D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D001932:Brain Neoplasms / Q000532:radiotherapy; D016543:Central Nervous System Neoplasms / Q000532:radiotherapy*; D002648:Child; D002675:Child, Preschool; D004337:Drug Carriers; D005910:Glioma / Q000532:radiotherapy; D006801:Humans; D007278:Injections, Spinal; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008875:Middle Aged
D000911:Antibodies, Monoclonal; D004337:Drug Carriers; D007457:Iodine Radioisotopes